Cayla JA - Search Results

1

Capture-recapture and anti-tuberculosis drug prescriptions, Balearic Islands, Spain, 2010-2012.

Gimenez-Duran J, Galmes-Truyols A, Gonzalez-Cortijo T, Portell-Arbona M, Bosch-Isabel C, Vanrell-Berga JM, Nicolau-Riutort A, Cayla JA. Gimenez-Duran J, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 2018 Jul 1;22(7):754-759. doi: 10.5588/ijtld.17.0303. Int J Tuberc Lung Dis. 2018. PMID: 29914600

2

Severe hepatotoxicity due to anti-tuberculosis drugs in Spain.

Tost JR, Vidal R, Caylà J, Díaz-Cabanela D, Jiménez A, Broquetas JM; Study Group for Severe Hepatotoxicity due to Anti-tuberculosis Drugs. Tost JR, et al. Int J Tuberc Lung Dis. 2005 May;9(5):534-40. Int J Tuberc Lung Dis. 2005. PMID: 15875925

3

Tuberculosis clinical units improve contact tracing.

Brugueras S, Orcau À, Millet JP, Espinosa L, de Andrés A, Gorrindo P, Caylà JA. Brugueras S, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 2016 Dec 1;20(12):1572-1579. doi: 10.5588/ijtld.16.0147. Int J Tuberc Lung Dis. 2016. PMID: 28000581

4

Characteristics of tuberculosis patients who generate secondary cases.

Rodrigo T, Caylà JA, García de Olalla P, Galdós-Tangüis H, Jansà JM, Miranda P, Brugal T. Rodrigo T, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 1997 Aug;1(4):352-7. Int J Tuberc Lung Dis. 1997. PMID: 9432392

5

Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.

Jansà JM, Serrano J, Caylà JA, Vidal R, Ocaña I, Español T. Jansà JM, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 1998 Feb;2(2):140-6. Int J Tuberc Lung Dis. 1998. PMID: 9580481

6

Effectiveness of tuberculosis control programmes in prisons, Barcelona 1987-2000.

Rodrigo T, Caylà JA, García de Olalla P, Brugal MT, Jansà JM, Guerrero R, Marco A, Martín V. Rodrigo T, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 2002 Dec;6(12):1091-7. Int J Tuberc Lung Dis. 2002. PMID: 12546117

7

Current status of treatment completion and fatality among tuberculosis patients in Spain.

Caylà JA, Caminero JA, Rey R, Lara N, Vallés X, Galdós-Tangüis H; Working Group on Completion of Tuberculosis Treatment in Spain. Caylà JA, et al. Int J Tuberc Lung Dis. 2004 Apr;8(4):458-64. Int J Tuberc Lung Dis. 2004. PMID: 15141739

8

Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment.

Català L, Orcau A, García de Olalla P, Millet JP, Rodríguez-Mondragón A, Caylà JA; TB-HIV Working Group. Català L, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 2011 Feb;15(2):263-9, i. Int J Tuberc Lung Dis. 2011. PMID: 21219692

9

Screening for active tuberculosis in high-risk groups.

Jiménez-Fuentes MA, Augé CM, Gómez MN, Peiró JS, de Souza Galvao ML, Maldonado J, Molina-Pinargote I, Orcau A, Cayla JA. Jiménez-Fuentes MA, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 2014 Dec;18(12):1459-65. doi: 10.5588/ijtld.14.0271. Int J Tuberc Lung Dis. 2014. PMID: 25517812

10

Tuberculosis in recipients of solid-organ transplants during 1995-2015 in Cali, Colombia.

García-Goez JF, Munera GA, Rojas V, Pacheco R, Caylá JA, Miro JM. García-Goez JF, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1155-1159. doi: 10.5588/ijtld.16.0945. Int J Tuberc Lung Dis. 2017. PMID: 29037296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page